<?xml version='1.0' encoding='utf-8'?>
<document id="17489884"><sentence text="Inherited long QT syndrome revealed by antifungals drug-drug interaction." /><sentence text="A 14-year-old Tahitian girl with acute myeloid leukaemia and a suspected mucormucosis infection was treated with intravenous voriconazole and caspofungin"><entity charOffset="125-137" id="DDI-PubMed.17489884.s2.e0" text="voriconazole" /><entity charOffset="142-153" id="DDI-PubMed.17489884.s2.e1" text="caspofungin" /><pair ddi="false" e1="DDI-PubMed.17489884.s2.e0" e2="DDI-PubMed.17489884.s2.e0" /><pair ddi="false" e1="DDI-PubMed.17489884.s2.e0" e2="DDI-PubMed.17489884.s2.e1" /></sentence><sentence text=" Because of worsening of fungal infection, voriconazole was switched to posaconazole"><entity charOffset="43-55" id="DDI-PubMed.17489884.s3.e0" text="voriconazole" /><entity charOffset="72-84" id="DDI-PubMed.17489884.s3.e1" text="posaconazole" /><pair ddi="false" e1="DDI-PubMed.17489884.s3.e0" e2="DDI-PubMed.17489884.s3.e0" /><pair ddi="false" e1="DDI-PubMed.17489884.s3.e0" e2="DDI-PubMed.17489884.s3.e1" /></sentence><sentence text=" During the switch, the patient presented with QT interval prolongation with 'torsades de pointes' and reversible cardiac arrest" /><sentence text=" Voriconazole plasma level measured 15 h after the last administration was 7 mg/L"><entity charOffset="1-13" id="DDI-PubMed.17489884.s5.e0" text="Voriconazole" /></sentence><sentence text=" Genotyping suggested that the patient was an extensive metabolizer with respect to CYP2C9 and CYP2C19" /><sentence text=" The association of antifungal agents with pro-arrhythmogenic drugs and other risk factors led to torsades de pointes and the revealing of inherited QT syndrome" /><sentence text="" /></document>